William Blair initiated coverage on shares of Health Catalyst (NASDAQ:HCAT) in a report issued on Monday, BenzingaRatingsTable reports. The brokerage issued an outperform rating on the stock.
HCAT has been the subject of a number of other reports. Evercore ISI assumed coverage on shares of Health Catalyst in a research report on Monday. They issued an outperform rating and a $50.00 price target for the company. Leerink Swann assumed coverage on shares of Health Catalyst in a research report on Monday. They issued an outperform rating and a $55.00 price target for the company. Finally, SunTrust Banks assumed coverage on shares of Health Catalyst in a research report on Monday. They issued a buy rating and a $53.00 price target for the company. Eight investment analysts have rated the stock with a buy rating, The stock presently has a consensus rating of Buy and a consensus target price of $51.29.
Shares of HCAT opened at $43.66 on Monday. Health Catalyst has a 1-year low of $36.29 and a 1-year high of $49.85.
Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.